Alice Bergamini

Alice Bergamini is a University Researcher at Vita-Salute San Raffaele University, specializing in Obstetrics and Gynaecology. She actively contributes to gynaecological oncology research and clinical trials.

• Position: University Researcher (fixed-term) at Vita-Salute San Raffaele University (2022–2025)
• Research Focus: Ovarian cancer, immunotherapy, molecular tumor boards, and rare gynaecological cancers

Her recent work explores CAR T-cell therapy for colorectal cancer metastases, real-world data on PARP inhibitors, and the role of radiotherapy in granulosa cell tumors. She also investigates endometriosis-related ovarian cancers and immune cell interactions in epithelial ovarian tumors.

She received the Giorgio Pardi Foundation Award '12x2012' in 2013. Her affiliations include the Multicenter Italian Trials in Ovarian Cancer (Fellow, 2019–present) and the Innovation Committee of the EOTTD (2018–present).

• 2025: Systemic CAR T-cell targeting of colorectal cancer liver metastases
• 2024: MITO39 trial on ovarian cancer maintenance therapy
• 2024: Real-world niraparib use in platinum-sensitive relapsed ovarian cancer
• 2024: Reproductive outcomes after conservative treatment of MOGCTs
• 2024: Molecular tumor boards for clinical pathway innovation
• 2023: CD4 CAR-T cell exacerbation of cytokine release syndrome
• 2023: Immune cell interactions in epithelial ovarian cancer
• 2023: Role of radiotherapy in ovarian granulosa cell tumors